SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: CORRESP
Document Type: CORRESP
Date Filed: 2024-09-30
Accession Number: 0001213900-24-083429
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390024083429/filename1.htm

Chunk 0 of 1
Word Count: 266
Character Count: 1736

Document Content:

Roth
Capital Markets, LLC

888 San Clemente Drive

Newport Beach, CA 92660

September

VIA
EDGAR

Tamika Sheppard

Joe McCann

Tracie Mariner

Vanessa Robertson

Securities
and Exchange Commission

Division
of Corporate Finance

F Street, N.E.

Washington,

Re:	Synergy
CHC Corp. (the “Company”)

File

Registration
Statement on Form S-1

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as
amended (the “Securities Act”), Roth Capital Markets, LLC, as representative of the underwriters of the offering, hereby
joins the request of the Company that the effective date of the above-captioned Registration Statement be accelerated so as to permit
it to become effective on Wednesday, October 2, 2024 at 4:30 p.m., Eastern time, or as soon thereafter as practicable.

Pursuant
to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act, we, acting on behalf
of the several underwriters, wish to advise you that, through September 26, 2024, we distributed to each underwriter or dealer, who is
reasonably anticipated to be invited to participate in the distribution of the security, as many copies, as well as “E-red”
copies of the Preliminary Prospectus dated September 16, 2024, as appears to be reasonable to secure adequate distribution of the preliminary
prospectus.

have complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature
Page Follows]

Very
truly yours,

ROTH
CAPITAL MARKETS, LLC

Aaron M. Gurewitz

Name:	Aaron
M. Gurewitz

Title:	President
& Head of Investment Banking